TABLE 2.

Baseline and changes in serum lipid/lipoprotein profiles in response to diets low in SFAs with varying unsaturated fatty acid profiles for 28 d in participants with or at risk for MetS¹

	Baseline2	Canola oil	CanolaOleic	CanolaDHA	Corn/Saff	Flax/Saff
Total cholesterol, mmol/L	5.48 ± 0.10	−0.58 ± 0.0513,a,b	−0.61 ± 0.063,a,b	−0.54 ± 0.063,a	−0.62 ± 0.063,b	−0.68 ± 0.043,b
HDL cholesterol, mmol/L	1.22 ± 0.29	−0.04 ± 0.023,a	−0.02 ± 0.023,a	0.07 ± 0.023,b	−0.01 ± 0.02a	−0.04 ± 0.023,a
LDL cholesterol, mmol/L	4.26 ± 0.11	−0.54 ± 0.053	−0.55 ± 0.053	−0.58 ± 0.0543	−0.59 ± 0.053	−0.60 ± 0.0483
TG, mmol/L	1.75 ± 0.08	−0.14 ± 0.053,a	−0.07 ± 0.043,a	−0.50 ± 0.043,b	−0.19 ± 0.053,a	−0.17 ± 0.043,a
ApoA1, mmol/L	1.47 ± 0.02	−0.06 ± 0.01a	−0.05 ± 0.01a	−0.04 ± 0.01a	−0.07 ± 0.01a	−0.10 ± 0.013,b
ApoB, mmol/L	1.06 ± 0.03	−0.11 ± 0.013,a,b	−0.11 ± 0.013,a,b	−0.10 ± 0.013,a	−0.13 ± 0.013,b	−0.12 ± 0.0113,b

¹Values are means ± SEMs, n = 101. Means in a row without a common superscript letter differ, P < 0.05 (mixed-model post-hoc analysis). CanolaDHA, DHA-enriched high oleic acid–canola oil; CanolaOleic, high oleic acidcanola oil; Corn/Saff, corn oil and safflower oil blend; Flax/Saff, flax oil and safflower oil blend; MetS, metabolic syndrome.

²Baseline data were collected on day 1 when participants were first enrolled in the study prior to diet intervention.

³Different from baseline, P < 0.05.